Skip to content

Clinical trials

Phase 2 Hyperglycemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperglycemia Phase: Phase 2 Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20042
20051
20065
20073
20082
20093
20103
20111
20121
20132
20171
20182
20191
20201
20211
20221
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Unknown status4
Active, not recruiting3
Terminated3
Withdrawn3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Intermountain Health Care, Inc.2
Novartis Pharmaceuticals2
University of British Columbia2
Albert Einstein College of Medicine1
Anelixis Therapeutics, LLC1
Anhui Medical University1
Bastyr University1
Columbia University1
Daiichi Sankyo1
Danisco1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperglycemia35
Diabetes Mellitus, Type 210
Diabetes Mellitus8
Insulin Resistance7
Obesity4
Diabetes Mellitus, Type 13
Hypertension3
Hypoglycemia3
Breast Neoplasms2
Critical Illness2

Trials

Showing 51 to 35 of 35. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.